LADENBURG THALMANN FINANCIAL SERVICES INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 72 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$37,000
+270.0%
1,8500.0%0.00%
Q3 2019$10,000
-16.7%
1,8500.0%0.00%
Q2 2019$12,000
-20.0%
1,850
-19.6%
0.00%
Q1 2019$15,0000.0%2,300
+4.5%
0.00%
Q4 2018$15,000
+200.0%
2,200
+214.3%
0.00%
Q3 2018$5,000
+25.0%
7000.0%0.00%
Q2 2018$4,0000.0%7000.0%0.00%
Q1 2018$4,000
+33.3%
7000.0%0.00%
Q4 2017$3,000
-25.0%
7000.0%0.00%
Q3 2017$4,000
-69.2%
700
-68.2%
0.00%
Q2 2017$13,000
-38.1%
2,200
-24.1%
0.00%
Q1 2017$21,000
+950.0%
2,900
+190.0%
0.00%
Q4 2016$2,0001,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders